Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway. [electronic resource]
Producer: 20141029Description: 1182-92 p. digitalISSN:- 1743-6109
- Arteries -- physiopathology
- Benzopyrans -- therapeutic use
- Carbolines -- pharmacology
- Cyclic GMP -- metabolism
- Diabetes Mellitus, Type 2 -- physiopathology
- Drug Synergism
- Erectile Dysfunction -- drug therapy
- Ethanolamines -- therapeutic use
- Humans
- Imidazoles -- pharmacology
- Male
- Middle Aged
- Muscle Relaxation -- drug effects
- Muscle, Smooth, Vascular -- drug effects
- Nebivolol
- Nitric Oxide -- metabolism
- Penile Erection -- drug effects
- Penis -- blood supply
- Phosphodiesterase 5 Inhibitors -- pharmacology
- Piperazines -- pharmacology
- Purines -- pharmacology
- Sildenafil Citrate
- Sulfones -- pharmacology
- Tadalafil
- Triazines -- pharmacology
- Vardenafil Dihydrochloride
- Vasodilator Agents -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.